Timusamin - thymus bioregulator.

Timusamin®- thymus bioregulator.

Promotes physiological activation of immunity, accelerates the recovery of the immune system after exposure to extreme factors on the organism.

Thymus (thymus gland) refers to the system of the endocrine glands, is part of the immune system and is responsible for restoring the structural and functional properties of immune cells, as well as the correction of immune dysfunction through the T- and B-lymphocytes. Thymic hormones affect T lymphocytes past differentiation, promote completion of maturation of T cells, enhance the migration of bone marrow progenitor immunity gland. Furthermore, thymic hormones involved in the regulation of the hypothalamic-pituitary-gonadal system, providing a direct effect on the activity of relevant endocrine glands. Normal functioning of the thymus provides a high level of protection of anti-stress, anti-infective and anti-tumor immunity, normalizes autoimmune processes. For correction of the immune system and prevent violations hormone genesis occurring in various diseases, developed "Timusamin."

• Activates the synthesis of specific proteins in the cells of the thymus, thereby reconstructing the functional activity of the thymus, which prevents weakening of the immune system.
• Accelerates the recovery of the immune system after infectious diseases, chemotherapy and radiation therapy, effects on the extreme factors (including ionizing and microwave radiation).
• Recommended in anticipation of the autumn-winter and spring season for soft, physiological activation of immunity for the purpose of prevention of cold-viral diseases.

Clinical trials of "Timusamin" conducted on 124 patients undergoing prolonged exposure to low doses of ionizing radiation (including cancer patients after radiation and chemotherapy), and patients with postoperative trauma profile of septic complications.

Evaluating the effectiveness of the use of "Timusamin" made ​​on the basis of the dynamics of subjective complaints and objective indicators of laboratory and instrumental studies, as well as specialized immunological tests (number of T and B lymphocytes, the content of the different classes of immunoglobulins; the functional activity of T-lymphocytes; research activity of tissue enzymes) .

In clinical trials, "Timusamin" found that the exchange rate of its reception contributes noticeably improve the general condition and, above all, reduce the severity of asthenic syndrome characteristic of secondary immunodeficiency. Patients with inflammatory complications after surgery found a significant increase in the activity of tissue enzymes, indicating the intensification of the processes of tissue metabolism. Increased tissue metabolism in patients receiving "Timusamin" promotes intensive cleansing of the wound surface of necrotic tissue and accelerated wound epithelialization that shortens treatment of this category of patients. In patients with the effects of radiation and chemotherapy during the reception "Timusamin" observed accelerated normalization of immunological parameters in peripheral blood, improving overall health and reducing the incidence of infectious complications.

"Timusamin" is recommended to accelerate the recovery of the immune system after infectious diseases, chemotherapy and radiation therapy, effects on the various extreme factors (including ionizing and microwave radiation). "Timusamin" also recommended for persons older and elderly to maintain a stable function of the immune system, especially in the autumn and spring seasons. It is suitable for all categories of the population of the systematic application of "Timusamin" in autumn and winter (October-November) and spring (February-March) periods of the year for the purpose of prevention of cold-viral diseases.

"Timusamin" show all middle and senior age groups in the period of unfavorable climatic conditions as a means of preventing infectious diseases. As a basic tool "Timusamin" is recommended for the treatment of any disease, accompanied by immunodeficiency. The method of application "Timusamin" in combination with the therapy of the underlying disease greatly increases its effectiveness, and promotes a more favorable course of the disease.

Indication of use:

• Acute and chronic inflammatory diseases of various etiologies;
• pre- and postoperative periods for different surgical interventions;
• generalized infection;
• systemic connective tissue disease;
• autoimmune diseases of various etiologies;
• state after extreme stress loads;
• geriatric practice.

Dosing:

1-3 tablets 2-3 times a day for 10-15 minutes before meals with water without chewing. Course: 10-14 days. Repeat the course in 3-6 months.

Contraindications:

Individual intolerance to the product components, pregnancy, lactation.

Release format:

40 tablets per pack